Immunization

Walgreens has announced its commitment to getting ahead of an early and condensed flu season amid the COVID-19 pandemic.

Here's the coronavirus-related news from this week that you should know.

The pharmaceutical company increased production by more than 25% in the United States.

Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.

The US government and Moderna are collaborating to produce 100 million doses of investigational COVID-19 vaccine candidate mRNA-1273.

Keep up-to-date on flu vaccine options and counseling considerations, especially as coronavirus disease 2019 continues to strike.

Experts worry that the approval is prioritizing the economy and national prestige over safety.

Age, gender, race, and general health make the list of potential risk factors for shingles.

The report showed that the vaccination rate has quintupled over the last decade.

Three scientists discuss the global race for a COVID-19 vaccine.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.

Here's this week's roundup of the coronavirus-related news you should know.

By adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.

A global pharmacy organization is aiming to help pharmacists expand their role in immunization via a new resource.

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

The US government agreed to pay $1.95 billion for the first 100 million doses of Pfizer and BioNTech’s investigational candidate.

The Federal Vaccine Consultation Panel will allow industry leaders to share the questions, concerns, and needs of their constituencies related to the development and distribution planning of a COVID-19 vaccine.

The AZD1222 vaccine, made from a common cold virus present in chimpanzees, produced rapid neutralizing antibody levels against the SARS-CoV-2 virus.

A new computer model can help researchers predict the regional areas where vaccines are needed most.

Despite some anticipated hesitancy, demand for the novel coronavirus vaccine will be significant when it becomes available.

Moderna announced interim analysis results of its investigational COVID-19 vaccine candidate, mRNA-1273, from an ongoing phase 1 study.

Here's this week's roundup of the coronavirus-related news you should know.

A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.